Medications for Attention Deficit Hyperactivity Disorder (ADHD)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Attention Deficit Hyperactivity Disorder (ADHD).
Found 6 Approved Drugs for Attention Deficit Hyperactivity Disorder (ADHD)
methYLphenidate
Brand Names
Concerta, Jornay, Methylin, Quillivant, QuilliChew, Daytrana, Cotempla, methYLphenidate Transdermal, Metadate, Aptensio, Ritalin, Relexxii
methYLphenidate
Brand Names
Concerta, Jornay, Methylin, Quillivant, QuilliChew, Daytrana, Cotempla, methYLphenidate Transdermal, Metadate, Aptensio, Ritalin, Relexxii
Form: Patch, Tablet, Suspension, Capsule, Solution
Method of administration: Oral, Transdermal
FDA approval date: December 31, 1955
Classification: Central Nervous System Stimulant
JORNAY PM is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. JORNAY PM is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. ( 1 )
Intuniv
Generic Name
Guanfacine
Intuniv
Generic Name
Guanfacine
Form: Tablet
Method of administration: Oral
FDA approval date: October 17, 1995
Classification: Central alpha-2 Adrenergic Agonist
Guanfacine hydrochloride tablets are indicated in the management of hypertension. Guanfacine may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.
Clonidine
Brand Names
Nexiclon, Catapres-TTS-1, ONYDA, Duraclon, Clonidine Transdermal, Catapres-TTS-2, Catapres-TTS-3, Clonidine HCI
Clonidine
Brand Names
Nexiclon, Catapres-TTS-1, ONYDA, Duraclon, Clonidine Transdermal, Catapres-TTS-2, Catapres-TTS-3, Clonidine HCI
Form: Patch, Injection, Tablet, Suspension
Method of administration: Epidural, Oral, Intravenous, Transdermal
FDA approval date: January 03, 1995
Classification: Central alpha-2 Adrenergic Agonist
NEXICLON XR is indicated in the treatment of hypertension. NEXICLON XR may be employed alone or concomitantly with other antihypertensive agents. NEXICLON XR is a central alpha-adrenergic agonist indicated for: Treatment of hypertension ( 1 )
Vyvanse
Generic Name
Lisdexamfetamine Dimesylate
Vyvanse
Generic Name
Lisdexamfetamine Dimesylate
Form: Tablet, Capsule
Method of administration: Oral
FDA approval date: February 23, 2007
Classification: Central Nervous System Stimulant
Lisdexamfetamine dimesylate capsules and lisdexamfetamine dimesylate chewable tablets are indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older [see Clinical Studies ( 1.
Dexmethylphenidate
Brand Names
Azstarys, Focalin
Dexmethylphenidate
Brand Names
Azstarys, Focalin
Form: Tablet, Capsule
Method of administration: Oral
FDA approval date: November 30, 2001
Classification: Central Nervous System Stimulant
Dexmethylphenidate hydrochloride tablets is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Dexmethylphenidate hydrochloride tablets is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Showing 1-5 of 6
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances